These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29794872)

  • 1. A 3-Protein Expression Signature of Neuroblastoma for Outcome Prediction.
    Xie Y; Xu H; Fang F; Li Z; Zhou H; Pan J; Guo W; Zhu X; Wang J; Wu Y
    Am J Surg Pathol; 2018 Aug; 42(8):1027-1035. PubMed ID: 29794872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors.
    Veschi V; Petroni M; Bartolazzi A; Altavista P; Dominici C; Capalbo C; Boldrini R; Castellano A; McDowell HP; Pizer B; Frati L; Screpanti I; Gulino A; Giannini G
    Cell Death Dis; 2014 Mar; 5(3):e1100. PubMed ID: 24603328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation.
    Gu Y; Lv F; Xue M; Chen K; Cheng C; Ding X; Jin M; Xu G; Zhang Y; Wu Z; Zheng L; Wu Y
    J Exp Clin Cancer Res; 2018 Oct; 37(1):258. PubMed ID: 30359286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome.
    Cornero A; Acquaviva M; Fardin P; Versteeg R; Schramm A; Eva A; Bosco MC; Blengio F; Barzaghi S; Varesio L
    BMC Bioinformatics; 2012 Mar; 13 Suppl 4(Suppl 4):S13. PubMed ID: 22536959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron-specific hel-N1 and HuD as novel molecular markers of neuroblastoma: a correlation of HuD messenger RNA levels with favorable prognostic features.
    Ball NS; King PH
    Clin Cancer Res; 1997 Oct; 3(10):1859-65. PubMed ID: 9815574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial neural network classifier predicts neuroblastoma patients' outcome.
    Cangelosi D; Pelassa S; Morini M; Conte M; Bosco MC; Eva A; Sementa AR; Varesio L
    BMC Bioinformatics; 2016 Nov; 17(Suppl 12):347. PubMed ID: 28185577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma.
    Li P; Gao Y; Ji Z; Zhang X; Xu Q; Li G; Guo Z; Zheng B; Guo X
    J Pediatr Surg; 2004 Oct; 39(10):1512-9. PubMed ID: 15486896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathologic features of peripheral neuroblastic tumors].
    Yang BF; Fu LB; He LJ
    Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):305-10. PubMed ID: 24004586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
    Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
    Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of cell proliferation in human neuroblastoma: comparison with other prognostic factors.
    Mejía C; Navarro S; Pellín A; Ruíz A; Castel V; Llombart-Bosch A
    Oncol Rep; 2003; 10(1):243-7. PubMed ID: 12469176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic profiling in neuroblastoma.
    Quintás G; Yáñez Y; Gargallo P; Juan Ribelles A; Cañete A; Castel V; Segura V
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28113. PubMed ID: 31802629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of proliferating cell nuclear antigen (PCNA) immunostaining in neuroblastoma.
    Kawasaki H; Mukai K; Yajima S; Tanaka R; Takayama J; Takasaki Y; Ohira M
    Med Pediatr Oncol; 1995 May; 24(5):300-4. PubMed ID: 7700181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of proliferating cell nuclear antigen expression in human neuroblastoma.
    Oue T; Fukuzawa M; Kamata S; Okada A
    J Pediatr Surg; 1995 Apr; 30(4):528-32. PubMed ID: 7595826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples.
    De Preter K; Mestdagh P; Vermeulen J; Zeka F; Naranjo A; Bray I; Castel V; Chen C; Drozynska E; Eggert A; Hogarty MD; Izycka-Swieszewska E; London WB; Noguera R; Piqueras M; Bryan K; Schowe B; van Sluis P; Molenaar JJ; Schramm A; Schulte JH; Stallings RL; Versteeg R; Laureys G; Van Roy N; Speleman F; Vandesompele J
    Clin Cancer Res; 2011 Dec; 17(24):7684-92. PubMed ID: 22031095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].
    Pérel Y; Valteau-Couanet D; Michon J; Lavrand F; Coze C; Bergeron C; Notz A; Plantaz D; Chastagner P; Bernard F; Thomas C; Rubie H
    Arch Pediatr; 2004 Jul; 11(7):834-42. PubMed ID: 15234382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of proliferation and apoptosis in neuroblastoma. Their relation with other prognostic factors.
    del Carmen Mejía M; Navarro S; Pellín A; Ruíz A; Castel V; Llombart-Bosch A
    Arch Med Res; 2002; 33(5):466-72. PubMed ID: 12459317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR.
    Oberthuer A; Kaderali L; Kahlert Y; Hero B; Westermann F; Berthold F; Brors B; Eils R; Fischer M
    Clin Cancer Res; 2008 Oct; 14(20):6590-601. PubMed ID: 18927300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors.
    Maitra A; Yashima K; Rathi A; Timmons CF; Rogers BB; Shay JW; Gazdar AF
    Cancer; 1999 Feb; 85(3):741-9. PubMed ID: 10091748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma.
    Sahu D; Hsu CL; Lin CC; Yang TW; Hsu WM; Ho SY; Juan HF; Huang HC
    Oncotarget; 2016 Sep; 7(36):58022-58037. PubMed ID: 27517149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.